Athenex, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATNX research report →
About the company
Athenex, Inc. is a biopharmaceutical company primarily dedicated to the discovery, advancement, and commercialization of therapeutic agents for oncological conditions. Its operations are structured across three distinct platforms: an Oncology Innovation Platform, a Global Supply Chain Platform, and a Commercial Platform.
- CEO
- Yiu-Nam Lau F.R.C.P.,
- IPO
- 2017
- Employees
- 269
- HQ
- Buffalo, NY, US
Price Chart
- Market Cap
- $2.33M
- P/E
- -0.01
- P/S
- 0.02
- P/B
- -0.20
- EV/EBITDA
- -0.13
- Div Yield
- 0.00%
- Gross Margin
- 25.97%
- Op Margin
- -68.02%
- Net Margin
- -96.26%
- ROE
- 21.51%
- ROIC
- -54.47%
- Revenue
- $102.82M · -14.44%
- Net Income
- $-98,975,000 · 49.06%
- EPS
- $-15.13 · 59.53%
- Op Income
- $-69,935,000
- FCF YoY
- 49.60%
- 52W High
- $23.80
- 52W Low
- $0.08
- 50D MA
- $0.95
- 200D MA
- $3.35
- Beta
- 1.35
- Avg Volume
- 263.31K
Get TickerSpark's AI analysis on ATNX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 5, 23 | LAU JOHNSON YIU NAM | other | 8,382 |
| May 5, 23 | Kwan Rudolf | other | 3,603 |
| May 5, 23 | Cook Timothy DeVere | other | 368 |
| Apr 21, 23 | WU JINN | other | 6,513 |
| Apr 21, 23 | VIERLING JOHN | other | 6,513 |
| Apr 21, 23 | TSANG Benson Kwan Hung | other | 8,813 |
| Apr 21, 23 | Spiegel Robert J. | other | 2,300 |
| Apr 21, 23 | LAU JOHNSON YIU NAM | other | 8,736 |
| Apr 21, 23 | Kwan Rudolf | other | 3,755 |
| Apr 21, 23 | Fok Manson | other | 5,747 |
Our ATNX coverage
Recent articles, reports, and earnings notes.
No research on ATNX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ATNX report →Similar companies
Peers in the same neighborhood.